New Antimicrobial Drugs Discovery and Development

Antimicrobial resistance is threatening the management of infections such as pneumonia, tuberculosis, malaria, and AIDS. In the past, resistance could be handled by development of new drugs active against resistant microbes. However, the pharmaceutical industry has reduced its research efforts in infections; genomics has not delivered the anticipated novel therapeutics; new regulatory requirements have increased costs; antibiotic use in common infections—eg, bronchitis and sinusitis—is questioned; and, compared with other drugs, return on investments is lower for antimicrobials. 

  • Breaking Research of Drug Discovery
  • Novel Drug Targets
  • Drug Design and Synthesis
  • Next Generation Biotherapy

Related Conference of New Antimicrobial Drugs Discovery and Development

New Antimicrobial Drugs Discovery and Development Conference Speakers